Title:
【発明の名称】鬱病の治療におけるパロキセチン
Document Type and Number:
Japanese Patent JP2000513331
Kind Code:
A
Abstract:
Paroxetine or a pharmaceutically acceptable salt thereof is used for treating and/or preventing the following depression sub-types: adolescent, bipolar, elderly, major, minor, moderate, recurrent, refractory, severe unipolar, dysthymia, post natal, double depression, post psychotic, post viral, bereavement, primary, secondary and depression associated with withdrawal from substances of abuse such as alcohol, nicotine, cocaine, heroin, benzodiazepines, in human or non-human animals. A preferred salt of paroxetine is the hydrochloride, particularly in crystalline form, such as the hemi-hydratye.
Inventors:
Maurice Gleason
Application Number:
JP53314797A
Publication Date:
October 10, 2000
Filing Date:
March 17, 1997
Export Citation:
Assignee:
SmithKline Beecham Public Limited Company
International Classes:
A61K31/4525; A61P25/24; (IPC1-7): A61K31/445; A61K31/00
Attorney, Agent or Firm:
Aoyama Ryo (1 person outside)